N-Methyl-1-(1-methyl-1H-pyrazol-4-yl)methanamine
95%
- Product Code: 54794
CAS:
179873-43-9
| Molecular Weight: | 125.1716 g./mol | Molecular Formula: | C₆H₁₁N₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD02090919 | |
| Melting Point: | Boiling Point: | 202.7 °C at 760 mmHg | |
| Density: | 1.05g/cm3 | Storage Condition: | room temperature |
Product Description:
This compound is primarily used in the field of medicinal chemistry as a building block for the synthesis of various pharmaceutical agents. Its structure is particularly valuable in the development of small molecule inhibitors that target specific enzymes or receptors involved in disease pathways. For instance, it has been explored in the creation of compounds that modulate the activity of kinases, making it relevant in cancer research and the development of targeted therapies. Additionally, its pyrazole moiety contributes to its potential use in designing drugs with anti-inflammatory or antimicrobial properties. Researchers also leverage its chemical framework to optimize drug-like properties such as solubility, stability, and bioavailability in early-stage drug discovery.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €68.14 |
+
-
|
N-Methyl-1-(1-methyl-1H-pyrazol-4-yl)methanamine
This compound is primarily used in the field of medicinal chemistry as a building block for the synthesis of various pharmaceutical agents. Its structure is particularly valuable in the development of small molecule inhibitors that target specific enzymes or receptors involved in disease pathways. For instance, it has been explored in the creation of compounds that modulate the activity of kinases, making it relevant in cancer research and the development of targeted therapies. Additionally, its pyrazole moiety contributes to its potential use in designing drugs with anti-inflammatory or antimicrobial properties. Researchers also leverage its chemical framework to optimize drug-like properties such as solubility, stability, and bioavailability in early-stage drug discovery.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :